The Effect of Periurethral Injection of Platelet Rich Plasma Versus Mid-urethral Sling in Treatment of Stress Urinary Incontinence : a Randomized Clinical Trial
1 other identifier
interventional
42
0 countries
N/A
Brief Summary
this study used to compare efficacy between platelet rich plasma periurethral injection versus mid urethral sling ( trans obturator tape ) in treatment of stress urinary incontinence
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2026
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 15, 2026
CompletedFirst Submitted
Initial submission to the registry
April 18, 2026
CompletedFirst Posted
Study publicly available on registry
April 24, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 15, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 30, 2027
April 24, 2026
October 1, 2025
1 year
April 18, 2026
April 18, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
objective assessment of SUI through cough stress test
after one and three months
Study Arms (1)
patients complaining of stress urinary incontinence based on urodynamic study
EXPERIMENTALGROUP 1: 21 patients allocated who have SUI ISD will receive PRP GROUP 2: 21 patient who have hypermobile urethra will receive TOT
Interventions
GROUP 1 : 21patient will have platelet rich plasma injected periurethral in intrinsic muscle weakness in stress urinary incontinence
GROUP 2 : (21) patient having SUI due to hypermobile urethra will have TOT
Eligibility Criteria
You may qualify if:
- stress urinary incontinence identified by urodynamic study
- patient agreement to undergo surgical treatment
You may not qualify if:
- previous GUS operation
- evidence of detrusor overactivity urinary system
- presence of pelvic organ prolapse
- malignancies of genitourinary system
- history of hemorrhagic disorders , on anti platelet treatment , uncontrolled diabetes mellitus .
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
mohamed Abdelhamid nasr El Din, Doctor of medicine
urogynecology unit ainshams university
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 18, 2026
First Posted
April 24, 2026
Study Start
April 15, 2026
Primary Completion (Estimated)
April 15, 2027
Study Completion (Estimated)
December 30, 2027
Last Updated
April 24, 2026
Record last verified: 2025-10
Data Sharing
- IPD Sharing
- Will not share
in informed consent all participants information will be only known by the research and investigator committee and their personal information will be kept with confidentiality